A growing global aging population and the prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders are driving demand for pharmaceutical products. Moreover, continued innovation in drug discovery and development, including advances in personalized medicine and genomics, are propelling the industry’s prospects.
Given this backdrop, investors could closely monitor fundamentally strong pharma stocks Amneal Pharmaceuticals, Inc. (AMRX), Collegium Pharmaceutical, Inc. (COLL), and Sanofi (SNY) for potential returns.
